Management of BP 220/110 mmHg

Critical First Step: Is this a Hypertensive Emergency or Urgency?

A BP of 220/110 mmHg requires immediate clinical assessment for end-organ damage. The distinction determines the entire management pathway.

Step 1: Classify the Situation

SCENARIO A: Hypertensive Emergency (End-organ Damage Present)

BP Reduction Goal (Critical)

• Reduce mean arterial pressure (MAP) by 10-20% in the first hour
• Then a further 5-15% over the next 2-6 hours
• Do NOT lower BP to "normal" acutely - overly aggressive reduction causes ischemic complications (stroke, blindness, renal failure)
• Target: <160/100 mmHg in first 2-6 hours, then gradual normalization over 24-48 hours

IV Drug Prescriptions (Choose Based on Clinical Scenario)

1. Labetalol (Most Versatile - First Choice in Most Emergencies)

Labetalol 20 mg IV slow bolus over 2 min
→ May repeat 40-80 mg IV every 10 min
→ OR Infusion: 0.5-2 mg/min IV, titrate to response
→ Maximum cumulative dose: 300 mg
→ Can follow with oral labetalol 200 mg PO when BP stabilizes

• Contraindications: Acute heart failure, bronchospasm/asthma, 2nd/3rd degree heart block
• Special use: Pregnancy, catecholamine excess (pheochromocytoma, cocaine), clonidine withdrawal, post-CABG

2. Nicardipine (IV Calcium Channel Blocker)

Nicardipine 5 mg/h IV infusion
→ Titrate by 2.5 mg/h every 5-15 min
→ Maximum: 15 mg/h
→ Reduce to 3 mg/h once target BP achieved
→ Administer via central line (or change peripheral site every 12h)

• Special use: Most hypertensive emergencies, hypertensive encephalopathy, ACS
• Avoid in: Advanced aortic stenosis

3. Sodium Nitroprusside (Severe/Refractory Cases)

Nitroprusside 0.25-0.5 mcg/kg/min IV infusion
→ Titrate every few minutes
→ Maximum: 8-10 mcg/kg/min (short-term only)
→ Use light-protected IV bag; monitor for thiocyanate toxicity if >48-72h

• Special use: Most emergencies; especially aortic dissection (combined with esmolol) and acute HF
• Caution: Reflex tachycardia, cyanide/thiocyanate toxicity with prolonged use

4. Esmolol (Aortic Dissection, Perioperative)

Esmolol 250-500 mcg/kg IV bolus over 1 min
→ Then 50-100 mcg/kg/min infusion
→ Titrate up to 300 mcg/kg/min as needed
→ Half-life ~10 min (rapidly titratable)

• Special use: Aortic dissection (first line, combined with nitroprusside or fenoldopam), perioperative

5. Nitroglycerin (Cardiac Emergency - ACS, Acute HF/Pulmonary Edema)

Nitroglycerin 5-10 mcg/min IV infusion
→ Increase by 5-10 mcg/min every 5-10 min
→ Titrate to BP response and symptom relief
→ Maximum: 200 mcg/min

• Special use: Coronary ischemia/MI, pulmonary edema, hypertensive urgency with cardiac involvement

Condition-Specific First-Choice Drugs (from Comprehensive Clinical Nephrology, Table 38.2)

SCENARIO B: Hypertensive Urgency (No End-organ Damage)

A prospective RCT showed that resting alone produces equivalent BP reduction to 40 mg telmisartan over 2 hours. Rest and reassurance first.

Oral Drug Prescriptions

Option 1: Captopril (ACE Inhibitor)

Captopril 12.5-25 mg PO
→ May repeat every 1-2 hours as needed
→ Onset: 15-30 min | Duration: 4-6h

• Avoid in bilateral renal artery stenosis, pregnancy, angioedema history

Option 2: Clonidine

Clonidine 0.1-0.2 mg PO
→ May repeat every 1-2 hours (max 0.8 mg total)
→ Onset: 30-60 min | Duration: 6-8h

• Caution: Sedation; do NOT discharge nonadherent patients on clonidine (rebound hypertension risk on abrupt stop)

Option 3: Labetalol

Labetalol 200-400 mg PO
→ May repeat every 2-3 hours
→ Onset: 30-120 min | Duration: 6-8h

• Avoid in asthma, heart block, decompensated heart failure

Option 4: Amlodipine (Long-acting CCB - If Starting Chronic Treatment)

Amlodipine 5-10 mg PO once daily
→ (Not for acute rapid lowering; for initiation of chronic therapy)

IMPORTANT: Sublingual short-acting nifedipine is CONTRAINDICATED - associated with higher rates of stroke, MI, and death from precipitous hypotension.

Monitoring and Supportive Measures

Sample Admission Orders (Hypertensive Emergency, No Specific Cause)

1. Admit to ICU / High Dependency Unit
2. BP monitoring every 5-15 min (arterial line preferred)
3. IV access x2
4. NPO or clear fluids
5. Labetalol 20 mg IV slow push over 2 min; may repeat 40-80 mg every 10 min (max 300 mg)
   OR Nicardipine 5 mg/h IV infusion, titrate to MAP reduction of 10-20% in 1st hour
6. ECG - 12 lead stat
7. Labs: CBC, BMP, LFTs, troponin, UA/microscopy
8. CXR stat
9. Head CT (non-contrast) if neurological signs
10. Fundoscopy
11. Strict I&O; Foley catheter
12. Cardiology/Nephrology consult as indicated
13. Once stable, transition to oral antihypertensive (labetalol 200 mg PO q12h or amlodipine 5 mg OD)

Important Notes

• Never use sublingual nifedipine - it is contraindicated (risk of precipitous hypotension, stroke, MI)
• Never lower BP too fast - maintain perfusion to brain, heart, and kidneys
• Identify and treat the underlying cause (medication non-adherence, renovascular disease, pheochromocytoma, primary aldosteronism, renal parenchymal disease, drug-induced)
• After stabilization, investigate for secondary hypertension if indicated
• Ensure follow-up within 1 week for any patient discharged with urgency

• Comprehensive Clinical Nephrology, 7th Ed., Table 38.1 & 38.2 (Pharmacologic Agents for Hypertensive Emergencies and Urgencies)
• Washington Manual of Medical Therapeutics (Hypertensive Crisis section)
• Tintinalli's Emergency Medicine, 9th Ed. (Treatment of Hypertensive Emergency)
• A 2025 systematic review in BMC Cardiovascular Disorders on management of extremely high BP confirms these guideline-based approaches remain current

Disclaimer: This is a clinical reference summary only. Prescriptions should always be individualized to the patient's full clinical picture, comorbidities, allergies, and current medications by a licensed clinician. This does not substitute for direct patient evaluation.